Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans.
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Cytokines have been implicated as immunological effector molecules that mediate beta cell destruction associated with insulin-dependent diabetes mellitus. In this report we demonstrate that the cytokine combination of human recombinant interleukin 1 beta (IL-1 beta), tumor necrosis factor alpha (TNF-alpha), and interferon gamma (IFN-gamma) induces the formation of nitric oxide by human islets. This combination of cytokines stimulates both the formation of the nitric oxide derivative, nitrite, and the accumulation of cGMP by human islets. The nitric oxide synthase inhibitor NG-monomethyl-L-arginine prevents formation of both cGMP and nitrite. IL-1 beta and IFN-gamma are sufficient to induce nitric oxide formation by human islets, whereas TNF-alpha potentiates nitrite production. This combination of cytokines (IL-1 beta, TNF-alpha, and IFN-gamma) also influences insulin secretion by human islets. Pretreatment of human islets with low concentrations of this cytokine combination (IL-1 beta at 15 units/ml, 0.7 nM TNF-alpha, and IFN-gamma at 150 units/ml) appears to slightly stimulate insulin secretion. Higher concentrations (IL-1 beta at 75 units/ml, 3.5 nM TNF-alpha, and IFN-gamma at 750 units/ml) inhibit insulin secretion from human islets, and the inhibitory effect is prevented by NG-monomethyl-L-arginine. This higher concentration of cytokines also induces the formation of an electron paramagnetic resonance-detectable g = 2.04 axial feature by human islets that is characteristic of the formation of an iron-dithio-dinitrosyl complex. The formation of this complex is prevented by NG-monomethyl-L-arginine, thus confirming that this cytokine combination induces the formation of nitric oxide by human islets. These results indicate that nitric oxide mediates the inhibitory effects of cytokines on glucose-stimulated insulin secretion by human islets and suggest that nitric oxide may participate in beta-cell dysfunction associated with insulin-dependent diabetes mellitus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nitric oxide: physiology, pathophysiology, and pharmacology.
Moncada, S., Palmer, R. M., & Higgs, E. A. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06663-3 · Cited by 15,525
Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids
Green, L. C., Wagner, D. A., Glogowski, J., Skipper, P. L., Wishnok, J. S., & Tannenbaum, S. R. (1982) · Analytical Biochemistry · doi:10.1016/0003-2697(82)90118-x · Cited by 12,077
Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme.
Bredt, D. S., & Snyder, S. H. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.2.682 · Cited by 3,284
Pathologic anatomy of the pancreas in juvenile diabetes mellitus
Gepts, W. (1965) · Diabetes · doi:10.2337/diab.14.10.619 · Cited by 1,345
Stuehr, D. J., Cho, H. J., Kwon, N. S., Weise, M. F., & Nathan, C. F. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.17.7773 · Cited by 816
Biological Roles of Nitric Oxide
Snyder, S. H., & Bredt, D. S. (1992) · Scientific American · doi:10.1038/scientificamerican0592-68 · Cited by 721
Aminoguanidine, a Novel Inhibitor of Nitric Oxide Formation, Prevents Diabetic Vascular Dysfunction
Corbett, J. A., Tilton, R. G., Chang, K., Hasan, K. S., Ido, Y., Wang, J. L., Sweetland, M. A., Lancaster, J. R., Williamson, J. R., & McDaniel, M. L. (1992) · Diabetes · doi:10.2337/diab.41.4.552 · Cited by 628
Self-citationNitrogen oxide levels in patients after trauma and during sepsis
OCHOA, J. B., UDEKWU, A. O., BILLIAR, T. R., CURRAN, R. D., CERRA, F. B., SIMMONS, R. L., & PEITZMAN, A. B. (1991) · Annals of Surgery · doi:10.1097/00000658-199111000-00013 · Cited by 599
Cytotoxicity of Human p I 7 Interleukin-1 for Pancreatic Islets of Langerhans
Bendtzen, K., Mandrup-Poulsen, T., Nerup, J., Nielsen, J. H., Dinarello, C. A., & Svenson, M. (1986) · Science · doi:10.1126/science.3086977 · Cited by 529
EPR demonstration of iron-nitrosyl complex formation by cytotoxic activated macrophages
Lancaster, J. R., & Hibbs, J. B. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.3.1223 · Cited by 507
Self-citation
Cited by
Nitric Oxide and Peroxynitrite in Health and Disease
Pacher, P., Beckman, J. S., & Liaudet, L. (2007) · Physiological Reviews · doi:10.1152/physrev.00029.2006 · Cited by 6,390
The Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors
Virág, L., & Szabó, C. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.3.375 · Cited by 1,373
Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets
Maedler, K., Sergeev, P., Ris, F., Oberholzer, J., Joller-Jemelka, H. I., Spinas, G. A., Kaiser, N., Halban, P. A., & Donath, M. Y. (2017) · Journal of Clinical Investigation · doi:10.1172/jci92172 · Cited by 1,114
The Pathogenesis of Insulin-Dependent Diabetes Mellitus
Epstein, F. H., Atkinson, M. A., & Maclaren, N. K. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411243312107 · Cited by 1,078
Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets
Maedler, K., Sergeev, P., Ris, F., Oberholzer, J., Joller-Jemelka, H. I., Spinas, G. A., Kaiser, N., Halban, P. A., & Donath, M. Y. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200215318 · Cited by 1,005
A choice of death - the signal-transduction of immune-mediated beta-cell apoptosis
Eizirik, D. L., & Mandrup-Poulsen, T. (2001) · Diabetologia · doi:10.1007/s001250100021 · Cited by 888
Nitric oxide signaling in health and disease
Lundberg, J. O., & Weitzberg, E. (2022) · Cell · doi:10.1016/j.cell.2022.06.010 · Cited by 826
Oslowski, C. M., Hara, T., O'Sullivan-Murphy, B., Kanekura, K., Lu, S., Hara, M., Ishigaki, S., Zhu, L. J., Hayashi, E., Hui, S. T., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.07.005 · Cited by 675
Inducible nitric oxide synthase in human diseases
Kröncke, K.-D., Fehsel, K., & Kolb-Bachofen, V (2001) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.1998.00648.x · Cited by 585
Inducible Nitric Oxide Synthase and Inflammatory Diseases
Zamora, R., Vodovotz, Y., & Billiar, T. R. (2000) · Molecular Medicine · doi:10.1007/bf03401781 · Cited by 558
The role of interleukin-1 in the pathogenesis of IDDM
Mandrup-Poulsen, T. (1996) · Diabetologia · doi:10.1007/bf00400649 · Cited by 543
Chartrain, N. A., Geller, D. A., Koty, P. P., Sitrin, N. F., Nussler, A. K., Hoffman, E. P., Billiar, T. R., Hutchinson, N. I., & Mudgett, J. S. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37441-0 · Cited by 394
Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets
Maedler, K., Sergeev, P., Ris, F., Oberholzer, J., Joller‐Jemelka, H. I., Spinas, G. A., Kaiser, N., Halban, P. A., & Donath, M. Y. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15318 · Cited by 363
Chronic tissue inflammation and metabolic disease
Lee, Y. S., & Olefsky, J. (2021) · Genes & Development · doi:10.1101/gad.346312.120 · Cited by 335
Molecular biology of nitric oxide synthases
Geller, D. A., & Billiar, T. R. (1998) · Cancer and Metastasis Reviews · doi:10.1023/a:1005940202801 · Cited by 330
Cytokines Induce Deoxyribonucleic Acid Strand Breaks and Apoptosis in Human Pancreatic Islet Cells
Delaney, C. A., Pavlović, D., Hoorens, A., PIPELEERS, D. G., & Eizirik, D. L. (1997) · Endocrinology · doi:10.1210/en.138.6.2610 · Cited by 320
Eizirik, D. L., Flodström, M., Karlsen, A. E., & Welsh, N. (1996) · Diabetologia · doi:10.1007/bf00403906 · Cited by 319
Cytokines suppress human islet function irrespective of their effects on nitric oxide generation.
Eizirik, D. L., Sandler, S., Welsh, N., Cetkovic-Cvrlje, M., Nieman, A., Geller, D. A., Pipeleers, D. G., Bendtzen, K., & Hellerström, C. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117188 · Cited by 317
Oxidative stress in streptozotocin-induced diabetic rats: effects of garlic oil and melatonin
Anwar, M. M., & Meki, A.-R. M. A. (2003) · Comparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology · doi:10.1016/s1095-6433(03)00114-4 · Cited by 312
Barshes, N. R., Wyllie, S., & Goss, J. A. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.1104649 · Cited by 307
Granata, R., Settanni, F., Biancone, L., Trovato, L., Nano, R., Bertuzzi, F., Destefanis, S., Annunziata, M., Martinetti, M., Catapano, F., et al. (2007) · Endocrinology · doi:10.1210/en.2006-0266 · Cited by 294
Greenberg, A. S., & McDaniel, M. L. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.32.s3.4.x · Cited by 290
Self-citationThe role of reactive oxygen species and proinflammatory cytokines in type 1 diabetes pathogenesis
Padgett, L. E., Broniowska, K. A., Hansen, P. A., Corbett, J. A., & Tse, H. M. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06826.x · Cited by 288
Self-citationResponse of Human Islets to Isolation Stress and the Effect of Antioxidant Treatment
Bottino, R., Balamurugan, A. N., Tse, H., Thirunavukkarasu, C., Ge, X., Profozich, J., Milton, M., Ziegenfuss, A., Trucco, M., & Piganelli, J. D. (2004) · Diabetes · doi:10.2337/diabetes.53.10.2559 · Cited by 277
Tissue Engineering Tools For Modulation of the Immune Response
Boehler, R. M., Graham, J. G., & Shea, L. D. (2011) · BioTechniques · doi:10.2144/000113754 · Cited by 263
Pileggi, A., Molano, R. D., Berney, T., Cattan, P., Vizzardelli, C., Oliver, R., Fraker, C., Ricordi, C., Pastori, R. L., Bach, F. H., et al. (2001) · Diabetes · doi:10.2337/diabetes.50.9.1983 · Cited by 260
Leisure-time physical activity and reduced plasma levels of obesity-related inflammatory markers
Pischon, T., Hankinson, S. E., Hotamisligil, G. S., Rifai, N., & Rimm, E. B. (2003) · Obesity Research · doi:10.1038/oby.2003.145 · Cited by 245
IL-1 produced and released endogenously within human islets inhibits beta cell function.
Arnush, M., Heitmeier, M. R., Scarim, A. L., Marino, M. H., Manning, P. T., & Corbett, J. A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci844 · Cited by 237
“Alone, IL-1, TNF, or IFN-g does not stimulate iNOS expression by human islets, nor do the combinations of TNF 1 IFN-g or IL-1 1 TNF (9, 14).”
BackgroundMethodResultInfluentialSelf-citationCorbett, J. A., & McDaniel, M. L. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.2.559 · Cited by 234
“nine (NMMA), aminoguanidine, and nitro-t-arginine methylester, prevent both the inhibitory effects of cytokines on insulin secretion, and cytokine-induced nitric oxide formation by rat, mouse, and human islets (11, 14-17).”
BackgroundSelf-citationDinitrosyl iron complexes with thiolate ligands: physico-chemistry, biochemistry and physiology
Vanin, A. F. (2009) · Nitric Oxide · doi:10.1016/j.niox.2009.03.005 · Cited by 217
Lortz, S., Tiedge, M., Nachtwey, T., Karlsen, A. E., Nerup, J., & Lenzen, S. (2000) · Diabetes · doi:10.2337/diabetes.49.7.1123 · Cited by 217
Liu, D., Pavlovic, D., Chen, M. C., Flodström, M., Sandler, S., & Eizirik, D. L. (2000) · Diabetes · doi:10.2337/diabetes.49.7.1116 · Cited by 210
Król, M., & Kepinska, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010056 · Cited by 187
Bottino, R., Balamurugan, A. N., Bertera, S., Pietropaolo, M., Trucco, M., & Piganelli, J. D. (2002) · Diabetes · doi:10.2337/diabetes.51.8.2561 · Cited by 177
“These stressful events may increase the production of either proinflammatory cytokines or free radicals by passenger leukocytes and by the islet cells themselves, leading ultimately to -cell dysfunction and death (14,15).”
BackgroundCetkovic-Cvrlje, M., & Eizirik, D. L. (1994) · Cytokine · doi:10.1016/1043-4666(94)90064-7 · Cited by 174
NF-κB and STAT1 control CXCL1 and CXCL2 gene transcription
Burke, S. J., Lu, D., Sparer, T. E., Masi, T., Goff, M. R., Karlstad, M. D., & Collier, J. J. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00347.2013 · Cited by 173
Suschek, C. V., Krischel, V., Bruch-Gerharz, D., Berendji, D., Krutmann, J., Kröncke, K.-D., & Kolb-Bachofen, V. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.10.6130 · Cited by 161
Advancing islet transplantation: from engraftment to the immune response
Gibly, R. F., Graham, J. G., Luo, X., Lowe, W. L., Hering, B. J., & Shea, L. D. (2011) · Diabetologia · doi:10.1007/s00125-011-2243-0 · Cited by 143
“During the early inflammatory response, macrophages and neutrophils contribute to the secretion of IL-1β [56] and TNF-α [57], which result in the release of toxic species and induce islet dysfunction [74].”
Interferons induce an antiviral state in human pancreatic islet cells
Hultcrantz, M., Hühn, M. H., Wolf, M., Olsson, A., Jacobson, S., Williams, B. R., Korsgren, O., & Flodström-Tullberg, M. (2007) · Virology · doi:10.1016/j.virol.2007.05.010 · Cited by 98
“Several observations suggest that IFNs, including an altered IFN production, contribute to the development of T1D in humans (Corbett et al., 1993; Foulis, 1996; Mandrup-Poulsen et al., 1985; Rhodes and Taylor, 1984; Skarsvik et al., 2006).”
BackgroundDula, S. B., Jecmenica, M., Wu, R., Jahanshahi, P., Verrilli, G. M., Carter, J. D., Brayman, K. L., & Nunemaker, C. S. (2010) · Cell Calcium · doi:10.1016/j.ceca.2010.07.007 · Cited by 83
“The cytokines chosen for this study are used widely as a means of inducing inflammatory responses in islets [2,4,27,28].”
MethodResultTheoretical analysis of biochemical pathways of nitric oxide release from vascular endothelial cells
Chen, K., & Popel, A. S. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.05.009 · Cited by 82
Effect of l-arginine-nitric oxide system on chemical-induced diabetes mellitus
Mohan, I. K., & Das, U. N. (1998) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(98)00129-4 · Cited by 80
Farnsworth, N. L., Walter, R. L., Hemmati, A., Westacott, M. J., & Benninger, R. K. P. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.679506 · Cited by 48
β-Cell Responses to Nitric Oxide
Broniowska, K. A., Oleson, B. J., & Corbett, J. A. (2014) · Vitamins & Hormones · doi:10.1016/b978-0-12-800174-5.00012-0 · Cited by 48
McGrowder, D., Ragoobirsingh, D., & Dasgupta, T. (2001) · Nitric Oxide · doi:10.1006/niox.2001.0360 · Cited by 39
Metadata
- Authors
- Corbett, J. A., Sweetland, M. A., Wang, J. L., Lancaster, J. R., & McDaniel, M. L.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1993-03
- Volume
- 90
- Issue
- 5
- Pages
- 1731-1735
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1972272933
- Cited by
- 411
- References
- 33
- FWCI
- 26.15
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.